137 related articles for article (PubMed ID: 8955135)
21. Mutant forms of growth factor-binding protein-2 reverse BCR-ABL-induced transformation.
Gishizky ML; Cortez D; Pendergast AM
Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10889-93. PubMed ID: 7479904
[TBL] [Abstract][Full Text] [Related]
22. Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase.
Besset V; Scott RP; Ibáñez CF
J Biol Chem; 2000 Dec; 275(50):39159-66. PubMed ID: 10995764
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of Bcr serine kinase by tyrosine phosphorylation.
Liu J; Wu Y; Ma GZ; Lu D; Haataja L; Heisterkamp N; Groffen J; Arlinghaus RB
Mol Cell Biol; 1996 Mar; 16(3):998-1005. PubMed ID: 8622703
[TBL] [Abstract][Full Text] [Related]
24. Association of Bcr-Abl with the proto-oncogene Vav is implicated in activation of the Rac-1 pathway.
Bassermann F; Jahn T; Miething C; Seipel P; Bai RY; Coutinho S; Tybulewicz VL; Peschel C; Duyster J
J Biol Chem; 2002 Apr; 277(14):12437-45. PubMed ID: 11790798
[TBL] [Abstract][Full Text] [Related]
25. Involvement of proline-rich tyrosine kinase 2 in platelet activation: tyrosine phosphorylation mostly dependent on alphaIIbbeta3 integrin and protein kinase C, translocation to the cytoskeleton and association with Shc through Grb2.
Ohmori T; Yatomi Y; Asazuma N; Satoh K; Ozaki Y
Biochem J; 2000 Apr; 347(Pt 2):561-9. PubMed ID: 10749687
[TBL] [Abstract][Full Text] [Related]
26. Identification of vascular endothelial growth factor receptor-1 tyrosine phosphorylation sites and binding of SH2 domain-containing molecules.
Ito N; Wernstedt C; Engström U; Claesson-Welsh L
J Biol Chem; 1998 Sep; 273(36):23410-8. PubMed ID: 9722576
[TBL] [Abstract][Full Text] [Related]
27. Regulation of c-Fes tyrosine kinase activity by coiled-coil and SH2 domains: analysis with Saccharomyces cerevisiae.
Takashima Y; Delfino FJ; Engen JR; Superti-Furga G; Smithgall TE
Biochemistry; 2003 Apr; 42(12):3567-74. PubMed ID: 12653561
[TBL] [Abstract][Full Text] [Related]
28. Coexistence of phosphotyrosine-dependent and -independent interactions between Cbl and Bcr-Abl.
Gaston I; Johnson KJ; Oda T; Bhat A; Reis M; Langdon W; Shen L; Deininger MW; Druker BJ
Exp Hematol; 2004 Jan; 32(1):113-21. PubMed ID: 14725908
[TBL] [Abstract][Full Text] [Related]
29. Bcr and Abl interaction: oncogenic activation of c-Abl by sequestering Bcr.
Ling X; Ma G; Sun T; Liu J; Arlinghaus RB
Cancer Res; 2003 Jan; 63(2):298-303. PubMed ID: 12543778
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-4 induces association of the c-fes proto-oncogene product with phosphatidylinositol-3 kinase.
Izuhara K; Feldman RA; Greer P; Harada N
Blood; 1996 Nov; 88(10):3910-8. PubMed ID: 8916957
[TBL] [Abstract][Full Text] [Related]
31. Tyrosine phosphorylation of 3BP2 is indispensable for the interaction with VAV3 in chicken DT40 cells.
Chihara K; Kimura Y; Honjoh C; Yamauchi S; Takeuchi K; Sada K
Exp Cell Res; 2014 Mar; 322(1):99-107. PubMed ID: 24406398
[TBL] [Abstract][Full Text] [Related]
32. The SH2-containing adapter protein GRB10 interacts with BCR-ABL.
Bai RY; Jahn T; Schrem S; Munzert G; Weidner KM; Wang JY; Duyster J
Oncogene; 1998 Aug; 17(8):941-8. PubMed ID: 9747873
[TBL] [Abstract][Full Text] [Related]
33. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC
Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
[TBL] [Abstract][Full Text] [Related]
34. Association of the protein kinases c-Bcr and Bcr-Abl with proteins of the 14-3-3 family.
Reuther GW; Fu H; Cripe LD; Collier RJ; Pendergast AM
Science; 1994 Oct; 266(5182):129-33. PubMed ID: 7939633
[TBL] [Abstract][Full Text] [Related]
35. The signal transduction through Grb2/Ash in hematopoietic cells.
Odai H; Hanazono Y; Sasaki K; Iwamatu A; Yazaki Y; Hirai H
Leukemia; 1997 Apr; 11 Suppl 3():405-7. PubMed ID: 9209406
[TBL] [Abstract][Full Text] [Related]
36. High affinity IgG receptor activation of Src family kinases is required for modulation of the Shc-Grb2-Sos complex and the downstream activation of the nicotinamide adenine dinucleotide phosphate (reduced) oxidase.
Park RK; Erdreich-Epstein A; Liu M; Izadi KD; Durden DL
J Immunol; 1999 Dec; 163(11):6023-34. PubMed ID: 10570290
[TBL] [Abstract][Full Text] [Related]
37. The SH2 inositol 5-phosphatase Ship1 is recruited in an SH2-dependent manner to the erythropoietin receptor.
Mason JM; Beattie BK; Liu Q; Dumont DJ; Barber DL
J Biol Chem; 2000 Feb; 275(6):4398-406. PubMed ID: 10660611
[TBL] [Abstract][Full Text] [Related]
38. Cross-talk between phorbol ester-mediated signaling and tyrosine kinase proto-oncogenes. I. Activation of protein kinase C stimulates tyrosine phosphorylation and activation of ErbB2 and ErbB3.
Emkey R; Kahn CR
J Biol Chem; 1997 Dec; 272(49):31172-81. PubMed ID: 9388271
[TBL] [Abstract][Full Text] [Related]
39. Requirement of two specific tyrosine residues for the catalytic activity of Bcr serine/threonine kinase.
Wu Y; Liu J; Arlinghaus RB
Oncogene; 1998 Jan; 16(1):141-6. PubMed ID: 9467953
[TBL] [Abstract][Full Text] [Related]
40. Proto-oncogene products Vav and c-Cbl are involved in the signal transduction through Grb2/Ash in hematopoietic cells.
Hanazono Y; Odai H; Sasaki K; Iwamatsu A; Yazaki Y; Hirai H
Acta Haematol; 1996; 95(3-4):236-42. PubMed ID: 8677749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
